Frank Takkinen
Stock Analyst at Lake Street
(2.85)
# 2,577
Out of 4,670 analysts
679
Total ratings
41.4%
Success rate
1.5%
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGHT Sight Sciences | Reiterated: Buy | $12 | $8.26 | +45.28% | 28 | Aug 19, 2026 | |
| NSPR InspireMD | Reiterated: Buy | $4 | $0.8998 | +344.54% | 16 | Aug 18, 2026 | |
| ELUT Elutia | Reiterated: Buy | $5 | $0.9509 | +425.82% | 33 | Aug 18, 2026 | |
| LNSR LENSAR | Reiterated: Buy | $10 → $13 | $8.68 | +49.77% | 18 | Aug 14, 2026 | |
| CLBT Cellebrite DI | Rated: Buy | $21 → $15 | $11.05 | +35.75% | 2 | Aug 14, 2026 | |
| STXS Stereotaxis | Maintained: Buy | $4 → $3 | $1.42 | +111.27% | 39 | Aug 12, 2026 | |
| TELA TELA Bio | Reiterated: Buy | $2 | $0.6463 | +209.45% | 39 | Aug 11, 2026 | |
| AORT Artivion | Reiterated: Buy | $45 | $28.08 | +60.26% | 37 | Aug 7, 2026 | |
| RCEL AVITA Medical | Reiterated: Buy | $6 → $8 | $10.06 | -20.48% | 13 | Aug 7, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Buy | $50 | $22.32 | +124.01% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $0.9021 | +177.13% | 20 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $5.27 | +51.80% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $3.5 | $2.84 | +23.24% | 47 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.21 | +149.22% | 35 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $25 | $15.39 | +62.44% | 50 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $87.85 | +36.60% | 20 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $7 | $4.33 | +61.66% | 9 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $55 | $50.40 | +9.13% | 14 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $32 → $35 | $34.45 | +1.60% | 3 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $2.26 | +76.99% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $19.05 | +4.99% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $14.03 | +42.55% | 49 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $15.75 | +52.38% | 5 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $10.00 | +130.00% | 5 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.6491 | +516.24% | 7 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $135 | $81.86 | +64.92% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $15 | $8.98 | +67.04% | 9 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.75 | +700.00% | 17 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $62.36 | +140.54% | 28 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $3.12 | n/a | 18 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.13 | n/a | 11 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $5.18 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22.04 → $19.28 | $9.32 | n/a | 9 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 → $40 | $0.000001 | n/a | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $12 | $0.13 | n/a | 3 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1 | $3.30 | n/a | 4 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 → $10 | $3.88 | n/a | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.51 | $0.30 | n/a | 1 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $10 | $0.0003 | n/a | 3 | Mar 31, 2022 |
Sight Sciences
Aug 19, 2026
Reiterated: Buy
Price Target: $12
Current: $8.26
Upside: +45.28%
InspireMD
Aug 18, 2026
Reiterated: Buy
Price Target: $4
Current: $0.8998
Upside: +344.54%
Elutia
Aug 18, 2026
Reiterated: Buy
Price Target: $5
Current: $0.9509
Upside: +425.82%
LENSAR
Aug 14, 2026
Reiterated: Buy
Price Target: $10 → $13
Current: $8.68
Upside: +49.77%
Cellebrite DI
Aug 14, 2026
Rated: Buy
Price Target: $21 → $15
Current: $11.05
Upside: +35.75%
Stereotaxis
Aug 12, 2026
Maintained: Buy
Price Target: $4 → $3
Current: $1.42
Upside: +111.27%
TELA Bio
Aug 11, 2026
Reiterated: Buy
Price Target: $2
Current: $0.6463
Upside: +209.45%
Artivion
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $28.08
Upside: +60.26%
AVITA Medical
Aug 7, 2026
Reiterated: Buy
Price Target: $6 → $8
Current: $10.06
Upside: -20.48%
Tandem Diabetes Care
Aug 7, 2026
Reiterated: Buy
Price Target: $50
Current: $22.32
Upside: +124.01%
Aug 7, 2026
Reiterated: Buy
Price Target: $2.5
Current: $0.9021
Upside: +177.13%
Aug 7, 2026
Reiterated: Buy
Price Target: $8
Current: $5.27
Upside: +51.80%
Aug 7, 2026
Downgraded: Hold
Price Target: $14 → $3.5
Current: $2.84
Upside: +23.24%
Aug 6, 2026
Reiterated: Buy
Price Target: $8
Current: $3.21
Upside: +149.22%
Aug 4, 2026
Reiterated: Buy
Price Target: $30 → $25
Current: $15.39
Upside: +62.44%
Aug 3, 2026
Reiterated: Buy
Price Target: $120
Current: $87.85
Upside: +36.60%
Jul 30, 2026
Reiterated: Buy
Price Target: $5 → $7
Current: $4.33
Upside: +61.66%
Jul 30, 2026
Reiterated: Buy
Price Target: $50 → $55
Current: $50.40
Upside: +9.13%
Jul 30, 2026
Downgraded: Hold
Price Target: $32 → $35
Current: $34.45
Upside: +1.60%
Jul 30, 2026
Reiterated: Buy
Price Target: $4
Current: $2.26
Upside: +76.99%
Jul 30, 2026
Reiterated: Buy
Price Target: $20
Current: $19.05
Upside: +4.99%
Jul 29, 2026
Reiterated: Buy
Price Target: $20
Current: $14.03
Upside: +42.55%
Jul 14, 2026
Maintained: Buy
Price Target: $24
Current: $15.75
Upside: +52.38%
May 26, 2026
Reiterated: Buy
Price Target: $23
Current: $10.00
Upside: +130.00%
May 21, 2026
Reiterated: Buy
Price Target: $4
Current: $0.6491
Upside: +516.24%
May 6, 2026
Reiterated: Buy
Price Target: $110 → $135
Current: $81.86
Upside: +64.92%
Jan 23, 2026
Reiterated: Buy
Price Target: $20 → $15
Current: $8.98
Upside: +67.04%
Oct 7, 2025
Reiterated: Buy
Price Target: $6
Current: $0.75
Upside: +700.00%
Aug 27, 2025
Reiterated: Buy
Price Target: $150
Current: $62.36
Upside: +140.54%
Aug 9, 2024
Reiterated: Buy
Price Target: $2.5
Current: $3.12
Upside: n/a
Jul 22, 2024
Reiterated: Buy
Price Target: $10
Current: $4.13
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $4
Current: $5.18
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $22.04 → $19.28
Current: $9.32
Upside: n/a
May 31, 2023
Reiterated: Buy
Price Target: $150 → $40
Current: $0.000001
Upside: n/a
Feb 14, 2023
Maintained: Buy
Price Target: $4 → $12
Current: $0.13
Upside: n/a
Sep 29, 2022
Maintained: Buy
Price Target: $1
Current: $3.30
Upside: n/a
May 11, 2022
Maintained: Buy
Price Target: $14 → $10
Current: $3.88
Upside: n/a
Apr 5, 2022
Initiated Coverage: Buy
Price Target: $5.51
Current: $0.30
Upside: n/a
Mar 31, 2022
Downgraded: Hold
Price Target: $6 → $10
Current: $0.0003
Upside: n/a